Advertisement
Advertisement
U.S. markets open in 4 hours 27 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Western Magnesium Corporation (MLYF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0001+0.0001 (+9,900.00%)
At close: 02:37PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0000
Open0.0001
BidN/A x N/A
AskN/A x N/A
Day's Range0.0001 - 0.0001
52 Week Range0.0000 - 0.1058
Volume4,000
Avg. Volume5,800
Market Cap37.441M
Beta (5Y Monthly)0.34
PE Ratio (TTM)N/A
EPS (TTM)-0.0800
Earnings DateOct 02, 2023 - Oct 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MLYF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • WESTERN MAGNESIUM CORPORATION
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
  • CNW Group

    IIROC Trading Halt - WMG

    The following issues have been halted by IIROC:

  • News Direct

    Western Magnesium Announces AGM Results

    Washington, DC - TheNewswire - March 7, 2023 - Western Magnesium Corporation (WMC) (TSXV:WMG.V) (Frankfurt-3WM) (OTC:MLYF) (“Western Magnesium” or the “Company”) is pleased to announce all resoluti...

  • News Direct

    Western Magnesium Plans West Coast Expansion

    WASHINGTON, D.C. – TheNewswire - February 21, 2023 – Western Magnesium Corporation (WMC) (TSXV:WMG.V); (Frankfurt-3WM); (OTC:MLYF) (“Western Magnesium” or the “Company”) is pleased to announce its ...

Advertisement
Advertisement